Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
EVO - Evotec SE - Stock Price Chart
TickerEVO [NASD]
CompanyEvotec SE
IndustryDrug Manufacturers - Specialty & Generic
Market Cap3.58BEPS (ttm)-0.32
P/E-EPS this Y65.40%
Forward P/E37.81EPS next Y250.00%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
Dividend-Sales Q/Q-1.10%
Insider Own-Inst Own0.39%
Insider Trans-Inst Trans-
Short Float0.01%EarningsAug 29/b
Analyst Recom2.00Target Price17.60
Avg Volume26.08K52W Range7.80 - 13.49
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
BTM - Bitcoin Depot Inc. - Stock Price Chart
TickerBTM [NASD]
CompanyBitcoin Depot Inc.
IndustryCapital Markets
Market Cap132.44MEPS (ttm)1.01
P/E2.31EPS this Y-33.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.20EPS next 5Y-
P/B2.41EPS Q/Q290.00%
Dividend-Sales Q/Q5.90%
Insider Own53.44%Inst Own78.70%
Insider Trans0.00%Inst Trans14.02%
Short Float2.27%EarningsAug 14/b
Analyst Recom-Target Price9.00
Avg Volume361.92K52W Range2.56 - 11.15
Bitcoin Depot Inc. owns and operates a network of cryptocurrency kiosks in North America. It provides users to buy and sell bitcoin, litecoin, and ethereum cryptocurrencies; and engages in the sale of cryptocurrency to consumers at a network of retail locations through its BDCheckout product offering and through its website over the counter trade. The company was founded in 2016 and is headquartered in Atlanta, Georgia. Bitcoin Depot Inc. is a subsidiary of BT Assets, Inc.
BGLC - BioNexus Gene Lab Corp. - Stock Price Chart
CompanyBioNexus Gene Lab Corp.
IndustrySpecialty Chemicals
Market Cap17.17MEPS (ttm)-0.04
P/E-EPS this Y-146.90%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-2.00%
P/S1.65EPS next 5Y-
P/B2.37EPS Q/Q-86.20%
Dividend-Sales Q/Q4.00%
Insider Own58.83%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float5.32%Earnings-
Analyst Recom-Target Price-
Avg Volume2.82M52W Range0.65 - 17.88
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
PSHG - Performance Shipping Inc. - Stock Price Chart
CompanyPerformance Shipping Inc.
IndustryMarine Shipping
Market Cap20.46MEPS (ttm)2.52
P/E0.74EPS this Y106.20%
Forward P/E1.19EPS next Y0.00%
PEG0.07EPS past 5Y-39.70%
P/S0.18EPS next 5Y10.00%
P/B0.11EPS Q/Q-97.00%
Dividend-Sales Q/Q88.60%
Insider Own8.29%Inst Own6.50%
Insider Trans0.00%Inst Trans47.73%
Short Float7.03%EarningsJul 27/b
Analyst Recom2.00Target Price4.00
Avg Volume451.53K52W Range0.68 - 5.18
Aug-31-23 09:28AM Performance Shipping Inc. Announces Initiation of Analyst Coverage by Maxim Group (GlobeNewswire) +9.29%
Aug-25-23 09:42AM Netflix upgraded, Olaplex downgraded: Wall Street's top analyst calls (The Fly) +5.59%
Aug-21-23 09:28AM Performance Shipping Inc. Announces Completion of US$2 Million Share Buyback Plan and Initiates New US$2 Million Share Buyback Plan (GlobeNewswire)
Aug-16-23 09:28AM Performance Shipping Inc. Regains Compliance With Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Aug-07-23 09:28AM Performance Shipping Inc. Announces Entry Into New Revolving Credit Facility With Nordea Bank at Favorable Terms Resulting in No Debt Maturities Prior To Mid-2027 (GlobeNewswire) +8.65%
Jul-27-23 09:28AM Performance Shipping Inc. Reports Net Income of $18.4 Million, a Second Consecutive Record, 1.7 Million Shares Repurchased for the Second Quarter 2023, and Financial Results for the Second Quarter and Six Months Ended June 30, 2023 (GlobeNewswire) +5.13%
Jun-27-23 09:28AM Performance Shipping Inc. Announces Time Charter Contract With ST Shipping at Fixed Floor Rate of US$45,000 Per Day Plus 50/50 Profit Share for LR2 Tanker, M/T P. Aliki (GlobeNewswire)
Jun-21-23 09:28AM Performance Shipping Inc. Reports Record Net Income of $15.7 Million, 1.5 Million Shares Repurchased and Financial Results for the First Quarter Ended March 31, 2023 (GlobeNewswire)
May-03-23 09:16AM Performance Shipping Inc. Announces Filing of 2022 Annual Report on Form 20-F (GlobeNewswire)
Apr-21-23 04:10PM Performance Shipping Inc. Announces Receipt of Nasdaq Notice (GlobeNewswire)
Performance Shipping Inc. provides shipping transportation services through its tanker vessels worldwide. As of December 31, 2022, its fleet consisted of eight Aframax tanker vessels with a combined carrying capacity of 851,825 DWT. The company was incorporated in 2010 and is based in Athens, Greece.
CFFE - CF Acquisition Corp. VIII - Stock Price Chart
CompanyCF Acquisition Corp. VIII
IndustryShell Companies
Market Cap118.25MEPS (ttm)-0.37
P/E-EPS this Y480.40%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B77.89EPS Q/Q-240.60%
Dividend-Sales Q/Q-
Insider Own6.49%Inst Own26.27%
Insider Trans0.00%Inst Trans-86.44%
Short Float0.07%Earnings-
Analyst Recom-Target Price-
Avg Volume47.22K52W Range9.85 - 20.35
CF Acquisition Corp. VIII does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus its search on companies operating in the financial services, healthcare, real estate services, technology, and software industries. CF Acquisition Corp. VIII was incorporated in 2020 and is based in New York, New York.
KRKR - 36Kr Holdings Inc. - Stock Price Chart
Company36Kr Holdings Inc.
IndustryInternet Content & Information
Market Cap34.65MEPS (ttm)-0.24
P/E-EPS this Y124.30%
Forward P/E14.84EPS next Y-
PEG-EPS past 5Y56.90%
P/S0.76EPS next 5Y-
P/B0.93EPS Q/Q-271.80%
Dividend-Sales Q/Q3.30%
Insider Own16.44%Inst Own0.30%
Insider Trans0.00%Inst Trans69.78%
Short Float0.04%EarningsAug 31/b
Analyst Recom1.00Target Price1.49
Avg Volume45.10K52W Range0.71 - 1.48
36Kr Holdings Inc. provides content and business services in the People's Republic of China. It creates and distributes various content, including insightful reports on companies and timely market updates, as well as editorials and commentaries in various industries, such as technology, media and entertainment, consumer, retail, and healthcare. The company's business services include online advertising services; enterprise value-added services, such as integrated marketing, advertisement agent, offline events, and consulting services; and subscription services to individuals, institutional investors, and enterprises. 36Kr Holdings Inc. was founded in 2010 and is headquartered in Beijing, the People's Republic of China.
HRYU - Hanryu Holdings, Inc. - Stock Price Chart
CompanyHanryu Holdings, Inc.
CountrySouth Korea
IndustryInternet Content & Information
Market Cap250.60MEPS (ttm)-0.14
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
Dividend-Sales Q/Q-98.90%
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float0.01%Earnings-
Analyst Recom-Target Price-
Avg Volume383.01K52W Range3.41 - 9.50
Hanryu Holdings, Inc. operates FANTOO, an online social media platform that connects users worldwide that share similar interests. Its platform allows users to interact with other like-minded users to share their appreciation of various types of entertainment and cultures, create and monetize their content, enjoy other users content, engage in commerce, and experience a fandom community. The company was founded in 2018 and is based in Seoul, South Korea.
BDN - Brandywine Realty Trust - Stock Price Chart
CompanyBrandywine Realty Trust
IndustryREIT - Office
Market Cap752.27MEPS (ttm)0.14
P/E30.63EPS this Y349.50%
Forward P/E-EPS next Y0.00%
PEG6.13EPS past 5Y-13.70%
P/S1.48EPS next 5Y5.00%
P/B0.49EPS Q/Q-384.70%
Dividend17.35%Sales Q/Q1.50%
Insider Own1.00%Inst Own99.70%
Insider Trans0.00%Inst Trans-2.21%
Short Float7.57%EarningsJul 25/a
Analyst Recom3.10Target Price5.05
Avg Volume2.06M52W Range3.42 - 8.11
Brandywine Realty Trust (NYSE: BDN) is one of the largest, publicly traded, full-service, integrated real estate companies in the United States with a core focus in the Philadelphia and Austin markets. Organized as a real estate investment trust (REIT), we own, develop, lease and manage an urban, town center and transit-oriented portfolio comprising 162 properties and 22.8 million square feet as of June 30, 2023 which excludes assets held for sale. Our purpose is to shape, connect and inspire the world around us through our expertise, the relationships we foster, the communities in which we live and work, and the history we build together.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SWEENEY GERARD HPresident and CEOFeb 01Option Exercise6.47109,929711,2411,737,282Feb 02 07:44 PM
WIRTH TOMExecutive Vice President & CFOFeb 01Option Exercise6.4735,307228,436322,948Feb 02 06:48 PM
DEVUONO H JEFFREYEVP & Senior Managing DirectorFeb 01Option Exercise6.4725,046162,048294,528Feb 02 06:07 PM
REDD WILLIAM DEVP & Senior Managing DirectorFeb 01Option Exercise6.4722,934148,383184,653Feb 02 06:11 PM
Johnstone GeorgeEVP, OperationsFeb 01Option Exercise6.4719,399125,512293,585Feb 02 06:13 PM
NXPL - NextPlat Corp - Stock Price Chart
CompanyNextPlat Corp
IndustrySoftware - Application
Market Cap33.86MEPS (ttm)-1.01
P/E-EPS this Y52.10%
Forward P/E-EPS next Y-
PEG-EPS past 5Y72.60%
P/S3.05EPS next 5Y-
P/B1.09EPS Q/Q-34.80%
Dividend-Sales Q/Q3.40%
Insider Own56.37%Inst Own2.20%
Insider Trans0.00%Inst Trans2.83%
Short Float1.50%Earnings-
Analyst Recom-Target Price-
Avg Volume17.79K52W Range1.21 - 4.26
NextPlat Corp, together with its subsidiaries, provides mobile satellite services (MSS) solutions for satellite-enabled voice, data, personnel and asset tracking, machine-to-machine, and Internet of Things (IoT) connectivity services in Europe, North America, South America, the Asia & Pacific, and Africa. It offers satellite communications products, which enable users to make voice calls, send and receive text messages and emails, and transmit GPS location coordinates virtually; GPS enabled emergency locator distress beacons that enables essential communication between customers, and search and rescue organizations during emergency situations and pinpoint locational information to search and rescue services; and SolarTrack, an IoT tracking device powered by the sun for tracking and monitoring anything that moves or remote asset used outdoors. The company also offers GTCTrack, a subscription-based mapping and tracking portal that allows managers to track, command, and control assets in near-real-time. The company provides its solutions for businesses, governments, military, humanitarian organizations, and individual users. It offers its products and services directly to end users and reseller networks; operates e-commerce websites that offer a range of MSS products and solutions; Web3, an internet service built using decentralized blockchains; NextPlat Digital enable the use of a range of digital assets, such as non-fungible tokens; and offers portable satellite voice, data, and tracking solutions through various third-party e-commerce storefronts. The company was formerly known as Orbsat Corp. and changed its name to NextPlat Corp in January 2022. NextPlat Corp is headquartered in Coconut Grove, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Barreto RodneyDirectorDec 14Buy1.751,085,7141,900,0001,476,085Dec 20 12:46 PM
Fernandez Charles M.Chairman & CEODec 14Buy1.751,085,7141,900,0003,658,667Dec 20 12:47 PM
Phipps DavidPresident/CEO of Global OpsDec 14Buy1.7528,50049,875421,788Dec 20 12:47 PM
ENLV - Enlivex Therapeutics Ltd. - Stock Price Chart
CompanyEnlivex Therapeutics Ltd.
Market Cap29.23MEPS (ttm)-1.63
P/E-EPS this Y-108.40%
Forward P/E-EPS next Y10.10%
PEG-EPS past 5Y34.80%
P/S-EPS next 5Y-
P/B0.58EPS Q/Q12.90%
Dividend-Sales Q/Q-
Insider Own11.83%Inst Own9.50%
Insider Trans0.00%Inst Trans-13.28%
Short Float0.70%EarningsJun 26/b
Analyst Recom-Target Price15.00
Avg Volume22.69K52W Range1.72 - 4.92
Sep-11-23 08:00AM Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results (GlobeNewswire) -12.73%
Sep-07-23 08:00AM Enlivex to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-02-23 08:00AM Enlivex Announces Peer-Reviewed Publication in Frontiers in Immunology of Clinical Data Details Resolution of Acute Respiratory Distress Syndrome (ARDS) from two Phase I/II Trials Evaluating Allocetra in Patients with COVID-19 (GlobeNewswire)
Jul-31-23 08:00AM Enlivex Announces Dosing of First Patient Under The Amended Protocol Of Its Phase II trial Evaluating Allocetra In Patients With Sepsis (GlobeNewswire)
Jun-26-23 08:00AM Enlivex Announces First Quarter 2023 Financial Results and Provides a Business Update (GlobeNewswire)
Jun-06-23 08:00AM Enlivex to Present at the 2023 Jefferies Healthcare Conference (GlobeNewswire)
May-31-23 08:04AM Enlivex Selected for an Elevator Pitch Presentation and two additional Poster Presentations at the 2023 Annual Meeting of the International Society for Cell & Gene Therapy (GlobeNewswire)
May-08-23 08:00AM Enlivex Announces Issuance of European Patent Covering the Use of Allocetra to Prevent Cytokine Release Syndrome (CRS) Resulting from CAR T-Cell Therapy (GlobeNewswire) +9.12%
Apr-20-23 10:18AM We Think Enlivex Therapeutics (NASDAQ:ENLV) Needs To Drive Business Growth Carefully (Simply Wall St.)
Apr-19-23 08:00AM Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Use of Allocetra in Patients Receiving CAR T-Cell Therapy (GlobeNewswire)
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. The company has a collaboration agreement with BeiGene to evaluate the safety and efficacy of Allocetra in combination with tislelizumab, an anti-PD-1 immune checkpoint inhibitor for the treatment of patients with advanced-stage solid tumors. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel.